There are three main types of retinal detachments:
rhegmatogenous, tractional, and serous (exudative).
The outcome is often poor, with 67% of the patients becoming blind within 1 month - mainly due to
rhegmatogenous retinal detachment.
Contributed by ophthalmologists from Europe, the US, and Israel, the 19 chapters address the surgical and nonsurgical management of vitreoretinal disorders, including diabetic retinopathy; diabetic macular edema, with discussion of the use of anti-vascular endothelial growth factor drugs and diagnosis; proliferative diabetic retinopathy; the complications and management of diabetic vitrectomy; retinal venous occlusions;
rhegmatogenous retinal detachment, including vitrectomy, scleral buckling materials, and pneumatic retinopexy; the use of prophylaxis for retinal detachment; retinal detachment due to giant tears or dialysis; macular hole surgery; vitrectomy for epiretinal membranes; Irvine-Gass syndrome; and endophthalmitis.
This process plays a central role in various blinding conditions, which includes
rhegmatogenous retinal detachment, proliferative diabetic retinopathy and macular hole formation.
has launched a Phase II clinical trial for INS37217 Ophthalmic (denufosol tetrasodium) for the treatment of
rhegmatogenous retinal detachment (RRD).
today announced the launch of a Phase II clinical trial for INS37217 Ophthalmic (denufosol tetrasodium) for the treatment of
rhegmatogenous retinal detachment (RRD).
Kaiser KS, Trese MT, Williams GA: Adult retinopathy of prematurity: outcomes of
rhegmatogenous retinal detachments and retinal tears.
The overall global winner was Simon Mitchell of Queensland, Australia, with an image of an inferior
rhegmatogenous retinal detachment (pictured, above left).
They discuss orbital tumors, refractive surgery, conductive keratoplasty, glaucoma imaging, age- related macular degeneration, ocular and adnexal injuries in warfare, genetic testing and counseling, phacomorphic glaucoma, the management of subluxated lenses, craniopharyngioma, phacoemulsification in vitrectomized eyes, retinal cysts, and the management of
rhegmatogenous retinal detachment by vitreoretinal techniques.
President of Retina Consultants San Diego, will make a podium presentation on results from a Phase I/II placebo-controlled study of INS37217 Ophthalmic intravitreal injection in patients with
rhegmatogenous retinal detachment.
Additionally, Inspire has made a decision to discontinue enrollment as of April 2005 in its Phase 2 clinical trial for INS37217 Ophthalmic for the treatment of
rhegmatogenous retinal detachment.
In the case presented here, the retinal detachment is
rhegmatogenous, which means that it has occurred secondary to a full-thickness defect (break) in the sensory retina.
